Decades of slow-moving research, along with broader failures of the healthcare system, have left millions of people in daily ...
New study data showed treatment slowed signs of disease progression by 75% after three years, a finding that could have ...
The trial failure removes from development a treatment Acadia acquired in a 2022 buyout and that was seen as a potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback